By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

SRI International 

333 Ravenswood Avenue

Menlo Park  California  94025  U.S.A.
Phone: 866-451-5998 Fax: 650-859-2889


SEARCH JOBS

SRI International’s Biosciences Division carries out basic research, drug discovery and drug development, and provides contract services. SRI Biosciences has all of the resources necessary to take R&D from Idea to IND and Beyond™ —from initial discovery to human clinical trials—and specializes in cancer, immunology and inflammation, infectious disease, and neuroscience. SRI’s product pipeline has yielded marketed drugs, therapeutics currently in clinical trials, and additional programs in earlier stages. In its CRO business, SRI has helped government and other clients and partners advance well over 100 drugs into patient testing. SRI is also working to create the next generation of technologies in areas such as diagnostics, drug delivery, medical devices, and systems biology.


Key Statistics


Email: biosciences@sri.com
Ownership: Private

Web Site: SRI International
Employees: n/a
Symbol: 
 









Company News
Thermo Fisher Scientific (TMO) And SRI International Collaborate To Enhance Small Molecule Research 7/10/2017 10:39:46 AM
SRI International Awarded $4.7 Million In Agreements To Manufacture And Test Vaccine Against Venezuelan Equine Encephalitis 4/28/2017 6:09:53 AM
SRI International Receives U.S. FDA Clearance For Investigational New Drug Application Evaluating Novel Oral Treatment To Combat Radiation Exposure 3/31/2017 7:57:46 AM
SRI International Awarded Two BARDA Contracts To Provide Nonclinical Research Services 3/9/2017 9:16:52 AM
SRI International Appoints Two New Leaders To Its Executive Team 5/20/2016 6:21:39 AM
Bay Area's SRI International Spins Off Wearable Robotics Biz Superflex 4/25/2016 7:37:13 AM
SRI International Receives $19.8 Million NCI Contract For PREVENT Cancer Program 3/11/2016 6:21:21 AM
SRI International Receives $9 Million Contract To Support National Cancer Institute PREVENT Cancer Program 11/3/2015 6:59:50 AM
SRI International Biosciences Researchers Part Of Team Reporting New Cancer Therapy Strategy In Nature 10/29/2015 7:35:15 AM
SRI International Awarded $40 Million NICHD Contract to Develop New Contraceptive Products 10/28/2015 6:14:34 AM
12345678910...
//-->